| 2024年中报 | 2023年年报 | 2022年年报 | |
|---|---|---|---|
| 营业收入(元) | |||
| EMR/ESD类(元) | - | 350,852,843.58 | 254,352,025.17 |
| ERCP类(元) | - | 172,867,213.23 | 109,689,556.77 |
| EUS/EBUS类(元) | - | 43,435,229.85 | 23,815,388.80 |
| 代理经销(元) | - | 89,766,525.63 | 53,514,727.71 |
| 活检类(元) | - | 246,847,332.07 | 250,282,844.65 |
| 可视化产品类(元) | 13,763,924.20 | 97,442,907.06 | 190,242,517.86 |
| 扩张类(元) | - | 212,146,612.11 | 186,814,289.13 |
| 微波消融针(元) | - | 174,037,165.88 | 123,374,929.29 |
| 止血及闭合类(元) | - | 921,370,029.89 | 725,100,303.05 |
| 肿瘤消融设备(元) | - | 12,137,558.01 | 5,843,725.04 |
| 内镜耗材类(元) | 1,127,451,114.07 | - | - |
| 肿瘤介入类(元) | 111,217,088.89 | - | - |
| 其他(元) | 77,828,140.16 | 74,752,335.75 | 50,409,671.98 |
| 营业成本(元) | |||
| EMR/ESD类(元) | - | 131,591,277.57 | 111,214,808.19 |
| ERCP类(元) | - | 70,301,977.62 | 43,653,914.25 |
| EUS/EBUS类(元) | - | 26,990,052.01 | 13,172,491.76 |
| 代理经销(元) | - | 56,413,541.58 | 36,559,356.27 |
| 活检类(元) | - | 151,333,764.94 | 163,615,011.86 |
| 可视化产品类(元) | 6,752,040.30 | 62,199,412.34 | 110,603,693.45 |
| 扩张类(元) | - | 56,214,458.12 | 55,952,580.06 |
| 微波消融针(元) | - | 35,759,118.18 | 23,413,321.82 |
| 止血及闭合类(元) | - | 218,452,433.21 | 176,954,481.44 |
| 肿瘤消融设备(元) | - | 9,058,217.96 | 3,785,399.10 |
| 内镜耗材类(元) | 346,957,227.26 | - | - |
| 肿瘤介入类(元) | 29,569,002.84 | - | - |
| 其他(元) | 41,553,648.68 | 28,999,824.11 | 28,543,603.56 |
| 毛利(元) | |||
| EMR/ESD类(元) | - | 219,261,566.01 | 143,137,216.98 |
| ERCP类(元) | - | 102,565,235.61 | 66,035,642.52 |
| EUS/EBUS类(元) | - | 16,445,177.84 | 10,642,897.04 |
| 代理经销(元) | - | 33,352,984.05 | 16,955,371.44 |
| 活检类(元) | - | 95,513,567.13 | 86,667,832.79 |
| 可视化产品类(元) | 7,011,883.90 | 35,243,494.72 | 79,638,824.41 |
| 扩张类(元) | - | 155,932,153.99 | 130,861,709.07 |
| 微波消融针(元) | - | 138,278,047.70 | 99,961,607.47 |
| 止血及闭合类(元) | - | 702,917,596.68 | 548,145,821.61 |
| 肿瘤消融设备(元) | - | 3,079,340.05 | 2,058,325.94 |
| 内镜耗材类(元) | 780,493,886.81 | - | - |
| 肿瘤介入类(元) | 81,648,086.05 | - | - |
| 其他(元) | 36,274,491.48 | 45,752,511.64 | 21,866,068.42 |
| 毛利率(%) | |||
| EMR/ESD类(%) | - | 62.49 | 56.28 |
| ERCP类(%) | - | 59.33 | 60.20 |
| EUS/EBUS类(%) | - | 37.86 | 44.69 |
| 代理经销(%) | - | 37.16 | 31.68 |
| 活检类(%) | - | 38.69 | 34.63 |
| 可视化产品类(%) | 50.94 | 36.17 | 41.86 |
| 扩张类(%) | - | 73.50 | 70.05 |
| 微波消融针(%) | - | 79.45 | 81.02 |
| 止血及闭合类(%) | - | 76.29 | 75.60 |
| 肿瘤消融设备(%) | - | 25.37 | 35.22 |
| 内镜耗材类(%) | 69.23 | - | - |
| 肿瘤介入类(%) | 73.41 | - | - |
| 其他(%) | 46.61 | 61.21 | 43.38 |
| 收入构成(%) | |||
| EMR/ESD类(%) | - | 14.65 | 12.89 |
| ERCP类(%) | - | 7.22 | 5.56 |
| EUS/EBUS类(%) | - | 1.81 | 1.21 |
| 代理经销(%) | - | 3.75 | 2.71 |
| 活检类(%) | - | 10.30 | 12.68 |
| 可视化产品类(%) | 1.03 | 4.07 | 9.64 |
| 扩张类(%) | - | 8.86 | 9.47 |
| 微波消融针(%) | - | 7.26 | 6.25 |
| 止血及闭合类(%) | - | 38.46 | 36.74 |
| 肿瘤消融设备(%) | - | 0.51 | 0.30 |
| 内镜耗材类(%) | 84.75 | - | - |
| 肿瘤介入类(%) | 8.36 | - | - |
| 其他(%) | 5.85 | 3.12 | 2.55 |
| 毛利构成(%) | |||
| EMR/ESD类(%) | - | 14.16 | 11.87 |
| ERCP类(%) | - | 6.62 | 5.48 |
| EUS/EBUS类(%) | - | 1.06 | 0.88 |
| 代理经销(%) | - | 2.15 | 1.41 |
| 活检类(%) | - | 6.17 | 7.19 |
| 可视化产品类(%) | 0.77 | 2.28 | 6.60 |
| 扩张类(%) | - | 10.07 | 10.85 |
| 微波消融针(%) | - | 8.93 | 8.29 |
| 止血及闭合类(%) | - | 45.40 | 45.45 |
| 肿瘤消融设备(%) | - | 0.20 | 0.17 |
| 内镜耗材类(%) | 86.20 | - | - |
| 肿瘤介入类(%) | 9.02 | - | - |
| 其他(%) | 4.01 | 2.95 | 1.81 |